TPST - Tempest Therapeutics files for mixed shelf offering of up to $300M
2024-07-19 17:12:00 ET
More on Tempest Therapeutics
- Tempest falls after new trial data for liver cancer therapy
- Tempest Therapeutics reports Q1 results
- Seeking Alpha’s Quant Rating on Tempest Therapeutics
- Historical earnings data for Tempest Therapeutics
- Financial information for Tempest Therapeutics